nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketoprofen—CXCL8—uterine cancer	0.529	1	CbGaD
Ketoprofen—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.0601	0.236	CbGbCtD
Ketoprofen—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0419	0.164	CbGbCtD
Ketoprofen—CYP2C8—Progesterone—uterine cancer	0.0398	0.156	CbGbCtD
Ketoprofen—PTGS2—Etoposide—uterine cancer	0.0366	0.143	CbGbCtD
Ketoprofen—PTGS1—Etoposide—uterine cancer	0.0309	0.121	CbGbCtD
Ketoprofen—CYP2C9—Progesterone—uterine cancer	0.0278	0.109	CbGbCtD
Ketoprofen—CYP2C8—Etoposide—uterine cancer	0.0178	0.0699	CbGbCtD
Ketoprofen—CXCL8—myometrium—uterine cancer	0.00206	0.0583	CbGeAlD
Ketoprofen—CXCR1—lymph node—uterine cancer	0.00198	0.056	CbGeAlD
Ketoprofen—Mefenamic acid—AKR1C1—uterine cancer	0.00183	0.465	CrCbGaD
Ketoprofen—PTGS1—oviduct—uterine cancer	0.00179	0.0505	CbGeAlD
Ketoprofen—CXCL8—uterine cervix—uterine cancer	0.00161	0.0453	CbGeAlD
Ketoprofen—CXCL8—smooth muscle tissue—uterine cancer	0.00156	0.0441	CbGeAlD
Ketoprofen—CXCL8—decidua—uterine cancer	0.00153	0.0432	CbGeAlD
Ketoprofen—CXCL8—endometrium—uterine cancer	0.00145	0.041	CbGeAlD
Ketoprofen—SLC22A11—renal system—uterine cancer	0.00124	0.0351	CbGeAlD
Ketoprofen—SLC22A7—renal system—uterine cancer	0.00121	0.0343	CbGeAlD
Ketoprofen—PTGS1—artery—uterine cancer	0.00118	0.0335	CbGeAlD
Ketoprofen—PTGS2—artery—uterine cancer	0.00113	0.032	CbGeAlD
Ketoprofen—CXCL8—female gonad—uterine cancer	0.00109	0.0309	CbGeAlD
Ketoprofen—CXCL8—vagina—uterine cancer	0.00109	0.0307	CbGeAlD
Ketoprofen—Mefenamic acid—AKR1C3—uterine cancer	0.00106	0.27	CrCbGaD
Ketoprofen—Naproxen—AKR1C3—uterine cancer	0.00104	0.265	CrCbGaD
Ketoprofen—SLC22A11—female reproductive system—uterine cancer	0.000997	0.0281	CbGeAlD
Ketoprofen—SLCO1A2—renal system—uterine cancer	0.000735	0.0208	CbGeAlD
Ketoprofen—ABCC4—renal system—uterine cancer	0.000708	0.02	CbGeAlD
Ketoprofen—CXCL8—lymph node—uterine cancer	0.000704	0.0199	CbGeAlD
Ketoprofen—SLC22A8—renal system—uterine cancer	0.000702	0.0198	CbGeAlD
Ketoprofen—ABCC4—uterus—uterine cancer	0.00063	0.0178	CbGeAlD
Ketoprofen—ABCC4—female reproductive system—uterine cancer	0.000567	0.016	CbGeAlD
Ketoprofen—PTGS2—myometrium—uterine cancer	0.000547	0.0154	CbGeAlD
Ketoprofen—ABCC4—female gonad—uterine cancer	0.000516	0.0146	CbGeAlD
Ketoprofen—CYP2C8—renal system—uterine cancer	0.000514	0.0145	CbGeAlD
Ketoprofen—CYP2C8—endometrium—uterine cancer	0.000497	0.014	CbGeAlD
Ketoprofen—PTGS1—epithelium—uterine cancer	0.000449	0.0127	CbGeAlD
Ketoprofen—PTGS1—uterine cervix—uterine cancer	0.000445	0.0126	CbGeAlD
Ketoprofen—PTGS1—smooth muscle tissue—uterine cancer	0.000433	0.0122	CbGeAlD
Ketoprofen—PTGS2—epithelium—uterine cancer	0.000429	0.0121	CbGeAlD
Ketoprofen—PTGS2—uterine cervix—uterine cancer	0.000426	0.012	CbGeAlD
Ketoprofen—PTGS1—renal system—uterine cancer	0.000417	0.0118	CbGeAlD
Ketoprofen—PTGS2—smooth muscle tissue—uterine cancer	0.000414	0.0117	CbGeAlD
Ketoprofen—CYP2C8—female reproductive system—uterine cancer	0.000411	0.0116	CbGeAlD
Ketoprofen—PTGS1—endometrium—uterine cancer	0.000403	0.0114	CbGeAlD
Ketoprofen—PTGS2—renal system—uterine cancer	0.000398	0.0112	CbGeAlD
Ketoprofen—PTGS1—mammalian vulva—uterine cancer	0.00039	0.011	CbGeAlD
Ketoprofen—PTGS2—endometrium—uterine cancer	0.000385	0.0109	CbGeAlD
Ketoprofen—CYP2C8—vagina—uterine cancer	0.000372	0.0105	CbGeAlD
Ketoprofen—PTGS1—uterus—uterine cancer	0.000371	0.0105	CbGeAlD
Ketoprofen—CYP2C9—female reproductive system—uterine cancer	0.000365	0.0103	CbGeAlD
Ketoprofen—PTGS2—uterus—uterine cancer	0.000355	0.01	CbGeAlD
Ketoprofen—ALB—lymph node—uterine cancer	0.000342	0.00967	CbGeAlD
Ketoprofen—PTGS1—female reproductive system—uterine cancer	0.000334	0.00942	CbGeAlD
Ketoprofen—ABCC4—lymph node—uterine cancer	0.000332	0.00936	CbGeAlD
Ketoprofen—PTGS2—female reproductive system—uterine cancer	0.000319	0.00901	CbGeAlD
Ketoprofen—PTGS1—female gonad—uterine cancer	0.000304	0.00857	CbGeAlD
Ketoprofen—PTGS1—vagina—uterine cancer	0.000302	0.00852	CbGeAlD
Ketoprofen—PTGS2—female gonad—uterine cancer	0.00029	0.0082	CbGeAlD
Ketoprofen—PTGS2—vagina—uterine cancer	0.000288	0.00815	CbGeAlD
Ketoprofen—Vascular purpura—Epirubicin—uterine cancer	0.000197	0.00148	CcSEcCtD
Ketoprofen—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000196	0.00147	CcSEcCtD
Ketoprofen—Eczema—Epirubicin—uterine cancer	0.000196	0.00147	CcSEcCtD
Ketoprofen—Eye pain—Epirubicin—uterine cancer	0.000195	0.00147	CcSEcCtD
Ketoprofen—PTGS1—lymph node—uterine cancer	0.000195	0.00551	CbGeAlD
Ketoprofen—Chills—Etoposide—uterine cancer	0.000195	0.00147	CcSEcCtD
Ketoprofen—Sepsis—Doxorubicin—uterine cancer	0.000195	0.00146	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000195	0.00146	CcSEcCtD
Ketoprofen—Cardiac failure congestive—Epirubicin—uterine cancer	0.000194	0.00146	CcSEcCtD
Ketoprofen—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000194	0.00145	CcSEcCtD
Ketoprofen—Alopecia—Etoposide—uterine cancer	0.000192	0.00144	CcSEcCtD
Ketoprofen—Vomiting—Progesterone—uterine cancer	0.000192	0.00144	CcSEcCtD
Ketoprofen—Rash—Progesterone—uterine cancer	0.00019	0.00143	CcSEcCtD
Ketoprofen—Dermatitis—Progesterone—uterine cancer	0.00019	0.00143	CcSEcCtD
Ketoprofen—Headache—Progesterone—uterine cancer	0.000189	0.00142	CcSEcCtD
Ketoprofen—Increased appetite—Epirubicin—uterine cancer	0.000188	0.00141	CcSEcCtD
Ketoprofen—Diabetes mellitus—Doxorubicin—uterine cancer	0.000187	0.00141	CcSEcCtD
Ketoprofen—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000187	0.00141	CcSEcCtD
Ketoprofen—Dermatitis exfoliative—Epirubicin—uterine cancer	0.000187	0.0014	CcSEcCtD
Ketoprofen—Hepatic function abnormal—Doxorubicin—uterine cancer	0.000187	0.0014	CcSEcCtD
Ketoprofen—PTGS2—lymph node—uterine cancer	0.000187	0.00527	CbGeAlD
Ketoprofen—Photosensitivity—Doxorubicin—uterine cancer	0.000186	0.00139	CcSEcCtD
Ketoprofen—Decreased appetite—Dactinomycin—uterine cancer	0.000186	0.00139	CcSEcCtD
Ketoprofen—Dysgeusia—Etoposide—uterine cancer	0.000185	0.00139	CcSEcCtD
Ketoprofen—Renal impairment—Epirubicin—uterine cancer	0.000185	0.00139	CcSEcCtD
Ketoprofen—Dermatitis bullous—Epirubicin—uterine cancer	0.000184	0.00138	CcSEcCtD
Ketoprofen—Fatigue—Dactinomycin—uterine cancer	0.000184	0.00138	CcSEcCtD
Ketoprofen—Purpura—Epirubicin—uterine cancer	0.000183	0.00137	CcSEcCtD
Ketoprofen—Vascular purpura—Doxorubicin—uterine cancer	0.000182	0.00137	CcSEcCtD
Ketoprofen—Eczema—Doxorubicin—uterine cancer	0.000181	0.00136	CcSEcCtD
Ketoprofen—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000181	0.00136	CcSEcCtD
Ketoprofen—Eye pain—Doxorubicin—uterine cancer	0.000181	0.00136	CcSEcCtD
Ketoprofen—Cardiac failure—Epirubicin—uterine cancer	0.000181	0.00136	CcSEcCtD
Ketoprofen—Cardiac failure congestive—Doxorubicin—uterine cancer	0.00018	0.00135	CcSEcCtD
Ketoprofen—Nausea—Progesterone—uterine cancer	0.000179	0.00135	CcSEcCtD
Ketoprofen—Hyponatraemia—Epirubicin—uterine cancer	0.000177	0.00133	CcSEcCtD
Ketoprofen—Gastrointestinal haemorrhage—Epirubicin—uterine cancer	0.000176	0.00132	CcSEcCtD
Ketoprofen—Feeling abnormal—Dactinomycin—uterine cancer	0.000176	0.00132	CcSEcCtD
Ketoprofen—Ill-defined disorder—Etoposide—uterine cancer	0.000176	0.00132	CcSEcCtD
Ketoprofen—Anaemia—Etoposide—uterine cancer	0.000175	0.00131	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000175	0.00131	CcSEcCtD
Ketoprofen—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000174	0.00131	CcSEcCtD
Ketoprofen—Increased appetite—Doxorubicin—uterine cancer	0.000174	0.0013	CcSEcCtD
Ketoprofen—Migraine—Epirubicin—uterine cancer	0.000173	0.0013	CcSEcCtD
Ketoprofen—Dermatitis exfoliative—Doxorubicin—uterine cancer	0.000173	0.0013	CcSEcCtD
Ketoprofen—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000173	0.0013	CcSEcCtD
Ketoprofen—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000172	0.00129	CcSEcCtD
Ketoprofen—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000171	0.00129	CcSEcCtD
Ketoprofen—Renal impairment—Doxorubicin—uterine cancer	0.000171	0.00129	CcSEcCtD
Ketoprofen—Malaise—Etoposide—uterine cancer	0.000171	0.00128	CcSEcCtD
Ketoprofen—Dermatitis bullous—Doxorubicin—uterine cancer	0.000171	0.00128	CcSEcCtD
Ketoprofen—Face oedema—Epirubicin—uterine cancer	0.00017	0.00128	CcSEcCtD
Ketoprofen—Vertigo—Etoposide—uterine cancer	0.00017	0.00128	CcSEcCtD
Ketoprofen—Purpura—Doxorubicin—uterine cancer	0.000169	0.00127	CcSEcCtD
Ketoprofen—Abdominal pain—Dactinomycin—uterine cancer	0.000169	0.00127	CcSEcCtD
Ketoprofen—Cardiac failure—Doxorubicin—uterine cancer	0.000167	0.00125	CcSEcCtD
Ketoprofen—Convulsion—Etoposide—uterine cancer	0.000164	0.00123	CcSEcCtD
Ketoprofen—Hyponatraemia—Doxorubicin—uterine cancer	0.000164	0.00123	CcSEcCtD
Ketoprofen—Hypertension—Etoposide—uterine cancer	0.000163	0.00123	CcSEcCtD
Ketoprofen—Gastrointestinal haemorrhage—Doxorubicin—uterine cancer	0.000163	0.00122	CcSEcCtD
Ketoprofen—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000163	0.00122	CcSEcCtD
Ketoprofen—Abdominal pain upper—Epirubicin—uterine cancer	0.000161	0.00121	CcSEcCtD
Ketoprofen—Migraine—Doxorubicin—uterine cancer	0.000161	0.00121	CcSEcCtD
Ketoprofen—Discomfort—Etoposide—uterine cancer	0.000159	0.0012	CcSEcCtD
Ketoprofen—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.000159	0.00119	CcSEcCtD
Ketoprofen—Face oedema—Doxorubicin—uterine cancer	0.000157	0.00118	CcSEcCtD
Ketoprofen—Hypersensitivity—Dactinomycin—uterine cancer	0.000157	0.00118	CcSEcCtD
Ketoprofen—Gastritis—Epirubicin—uterine cancer	0.000156	0.00117	CcSEcCtD
Ketoprofen—Confusional state—Etoposide—uterine cancer	0.000156	0.00117	CcSEcCtD
Ketoprofen—Anaphylactic shock—Etoposide—uterine cancer	0.000155	0.00116	CcSEcCtD
Ketoprofen—Infection—Etoposide—uterine cancer	0.000154	0.00115	CcSEcCtD
Ketoprofen—Asthenia—Dactinomycin—uterine cancer	0.000153	0.00115	CcSEcCtD
Ketoprofen—Asthma—Epirubicin—uterine cancer	0.000152	0.00114	CcSEcCtD
Ketoprofen—Thrombocytopenia—Etoposide—uterine cancer	0.000151	0.00114	CcSEcCtD
Ketoprofen—Tachycardia—Etoposide—uterine cancer	0.000151	0.00113	CcSEcCtD
Ketoprofen—Hyperhidrosis—Etoposide—uterine cancer	0.000149	0.00112	CcSEcCtD
Ketoprofen—Pancreatitis—Epirubicin—uterine cancer	0.000149	0.00112	CcSEcCtD
Ketoprofen—Abdominal pain upper—Doxorubicin—uterine cancer	0.000149	0.00112	CcSEcCtD
Ketoprofen—Anorexia—Etoposide—uterine cancer	0.000147	0.00111	CcSEcCtD
Ketoprofen—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.000147	0.0011	CcSEcCtD
Ketoprofen—Diarrhoea—Dactinomycin—uterine cancer	0.000146	0.0011	CcSEcCtD
Ketoprofen—Gastritis—Doxorubicin—uterine cancer	0.000144	0.00108	CcSEcCtD
Ketoprofen—Asthma—Doxorubicin—uterine cancer	0.000141	0.00106	CcSEcCtD
Ketoprofen—Photosensitivity reaction—Epirubicin—uterine cancer	0.000139	0.00104	CcSEcCtD
Ketoprofen—Paraesthesia—Etoposide—uterine cancer	0.000139	0.00104	CcSEcCtD
Ketoprofen—Weight increased—Epirubicin—uterine cancer	0.000139	0.00104	CcSEcCtD
Ketoprofen—Pancreatitis—Doxorubicin—uterine cancer	0.000138	0.00104	CcSEcCtD
Ketoprofen—Weight decreased—Epirubicin—uterine cancer	0.000138	0.00103	CcSEcCtD
Ketoprofen—Dyspnoea—Etoposide—uterine cancer	0.000138	0.00103	CcSEcCtD
Ketoprofen—Somnolence—Etoposide—uterine cancer	0.000137	0.00103	CcSEcCtD
Ketoprofen—Drowsiness—Epirubicin—uterine cancer	0.000136	0.00102	CcSEcCtD
Ketoprofen—Vomiting—Dactinomycin—uterine cancer	0.000136	0.00102	CcSEcCtD
Ketoprofen—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000135	0.00101	CcSEcCtD
Ketoprofen—Rash—Dactinomycin—uterine cancer	0.000135	0.00101	CcSEcCtD
Ketoprofen—Decreased appetite—Etoposide—uterine cancer	0.000134	0.00101	CcSEcCtD
Ketoprofen—Renal failure—Epirubicin—uterine cancer	0.000134	0.001	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Etoposide—uterine cancer	0.000133	0.001	CcSEcCtD
Ketoprofen—Fatigue—Etoposide—uterine cancer	0.000133	0.001	CcSEcCtD
Ketoprofen—Stomatitis—Epirubicin—uterine cancer	0.000132	0.000994	CcSEcCtD
Ketoprofen—Jaundice—Epirubicin—uterine cancer	0.000132	0.000994	CcSEcCtD
Ketoprofen—Constipation—Etoposide—uterine cancer	0.000132	0.000992	CcSEcCtD
Ketoprofen—Conjunctivitis—Epirubicin—uterine cancer	0.000132	0.000991	CcSEcCtD
Ketoprofen—Sweating—Epirubicin—uterine cancer	0.00013	0.000978	CcSEcCtD
Ketoprofen—Haematuria—Epirubicin—uterine cancer	0.00013	0.000972	CcSEcCtD
Ketoprofen—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000129	0.000966	CcSEcCtD
Ketoprofen—Weight increased—Doxorubicin—uterine cancer	0.000128	0.000963	CcSEcCtD
Ketoprofen—Epistaxis—Epirubicin—uterine cancer	0.000128	0.000962	CcSEcCtD
Ketoprofen—Weight decreased—Doxorubicin—uterine cancer	0.000128	0.000957	CcSEcCtD
Ketoprofen—Feeling abnormal—Etoposide—uterine cancer	0.000127	0.000956	CcSEcCtD
Ketoprofen—Nausea—Dactinomycin—uterine cancer	0.000127	0.000952	CcSEcCtD
Ketoprofen—Agranulocytosis—Epirubicin—uterine cancer	0.000127	0.000952	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Etoposide—uterine cancer	0.000126	0.000949	CcSEcCtD
Ketoprofen—Drowsiness—Doxorubicin—uterine cancer	0.000126	0.000943	CcSEcCtD
Ketoprofen—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000125	0.000935	CcSEcCtD
Ketoprofen—Renal failure—Doxorubicin—uterine cancer	0.000124	0.000927	CcSEcCtD
Ketoprofen—Urticaria—Etoposide—uterine cancer	0.000123	0.000922	CcSEcCtD
Ketoprofen—Stomatitis—Doxorubicin—uterine cancer	0.000123	0.00092	CcSEcCtD
Ketoprofen—Jaundice—Doxorubicin—uterine cancer	0.000123	0.00092	CcSEcCtD
Ketoprofen—Rhinitis—Epirubicin—uterine cancer	0.000122	0.000918	CcSEcCtD
Ketoprofen—Abdominal pain—Etoposide—uterine cancer	0.000122	0.000917	CcSEcCtD
Ketoprofen—Conjunctivitis—Doxorubicin—uterine cancer	0.000122	0.000917	CcSEcCtD
Ketoprofen—Hepatitis—Epirubicin—uterine cancer	0.000122	0.000915	CcSEcCtD
Ketoprofen—Pharyngitis—Epirubicin—uterine cancer	0.000121	0.000908	CcSEcCtD
Ketoprofen—Sweating—Doxorubicin—uterine cancer	0.00012	0.000904	CcSEcCtD
Ketoprofen—Haematuria—Doxorubicin—uterine cancer	0.00012	0.0009	CcSEcCtD
Ketoprofen—Epistaxis—Doxorubicin—uterine cancer	0.000119	0.00089	CcSEcCtD
Ketoprofen—Visual impairment—Epirubicin—uterine cancer	0.000118	0.000882	CcSEcCtD
Ketoprofen—Agranulocytosis—Doxorubicin—uterine cancer	0.000117	0.00088	CcSEcCtD
Ketoprofen—Erythema multiforme—Epirubicin—uterine cancer	0.000115	0.000865	CcSEcCtD
Ketoprofen—Hypersensitivity—Etoposide—uterine cancer	0.000114	0.000855	CcSEcCtD
Ketoprofen—Tinnitus—Epirubicin—uterine cancer	0.000114	0.000853	CcSEcCtD
Ketoprofen—Flushing—Epirubicin—uterine cancer	0.000113	0.00085	CcSEcCtD
Ketoprofen—Rhinitis—Doxorubicin—uterine cancer	0.000113	0.000849	CcSEcCtD
Ketoprofen—Hepatitis—Doxorubicin—uterine cancer	0.000113	0.000847	CcSEcCtD
Ketoprofen—Pharyngitis—Doxorubicin—uterine cancer	0.000112	0.000841	CcSEcCtD
Ketoprofen—Asthenia—Etoposide—uterine cancer	0.000111	0.000832	CcSEcCtD
Ketoprofen—Chills—Epirubicin—uterine cancer	0.000109	0.000821	CcSEcCtD
Ketoprofen—Pruritus—Etoposide—uterine cancer	0.000109	0.000821	CcSEcCtD
Ketoprofen—Arrhythmia—Epirubicin—uterine cancer	0.000109	0.000818	CcSEcCtD
Ketoprofen—Visual impairment—Doxorubicin—uterine cancer	0.000109	0.000816	CcSEcCtD
Ketoprofen—Alopecia—Epirubicin—uterine cancer	0.000108	0.000809	CcSEcCtD
Ketoprofen—Erythema multiforme—Doxorubicin—uterine cancer	0.000107	0.000801	CcSEcCtD
Ketoprofen—Erythema—Epirubicin—uterine cancer	0.000106	0.000797	CcSEcCtD
Ketoprofen—Diarrhoea—Etoposide—uterine cancer	0.000106	0.000794	CcSEcCtD
Ketoprofen—Tinnitus—Doxorubicin—uterine cancer	0.000105	0.00079	CcSEcCtD
Ketoprofen—Flushing—Doxorubicin—uterine cancer	0.000105	0.000786	CcSEcCtD
Ketoprofen—Flatulence—Epirubicin—uterine cancer	0.000105	0.000785	CcSEcCtD
Ketoprofen—Tension—Epirubicin—uterine cancer	0.000104	0.000782	CcSEcCtD
Ketoprofen—Dysgeusia—Epirubicin—uterine cancer	0.000104	0.00078	CcSEcCtD
Ketoprofen—Nervousness—Epirubicin—uterine cancer	0.000103	0.000774	CcSEcCtD
Ketoprofen—Dizziness—Etoposide—uterine cancer	0.000102	0.000767	CcSEcCtD
Ketoprofen—Chills—Doxorubicin—uterine cancer	0.000101	0.00076	CcSEcCtD
Ketoprofen—Arrhythmia—Doxorubicin—uterine cancer	0.000101	0.000757	CcSEcCtD
Ketoprofen—Alopecia—Doxorubicin—uterine cancer	9.97e-05	0.000748	CcSEcCtD
Ketoprofen—Ill-defined disorder—Epirubicin—uterine cancer	9.85e-05	0.000739	CcSEcCtD
Ketoprofen—Vomiting—Etoposide—uterine cancer	9.83e-05	0.000738	CcSEcCtD
Ketoprofen—Erythema—Doxorubicin—uterine cancer	9.82e-05	0.000737	CcSEcCtD
Ketoprofen—Anaemia—Epirubicin—uterine cancer	9.81e-05	0.000736	CcSEcCtD
Ketoprofen—Rash—Etoposide—uterine cancer	9.74e-05	0.000731	CcSEcCtD
Ketoprofen—Dermatitis—Etoposide—uterine cancer	9.74e-05	0.000731	CcSEcCtD
Ketoprofen—Headache—Etoposide—uterine cancer	9.68e-05	0.000727	CcSEcCtD
Ketoprofen—Flatulence—Doxorubicin—uterine cancer	9.68e-05	0.000727	CcSEcCtD
Ketoprofen—Tension—Doxorubicin—uterine cancer	9.64e-05	0.000723	CcSEcCtD
Ketoprofen—Dysgeusia—Doxorubicin—uterine cancer	9.62e-05	0.000722	CcSEcCtD
Ketoprofen—Malaise—Epirubicin—uterine cancer	9.57e-05	0.000719	CcSEcCtD
Ketoprofen—Nervousness—Doxorubicin—uterine cancer	9.54e-05	0.000716	CcSEcCtD
Ketoprofen—Vertigo—Epirubicin—uterine cancer	9.54e-05	0.000716	CcSEcCtD
Ketoprofen—Palpitations—Epirubicin—uterine cancer	9.38e-05	0.000704	CcSEcCtD
Ketoprofen—Convulsion—Epirubicin—uterine cancer	9.2e-05	0.00069	CcSEcCtD
Ketoprofen—Nausea—Etoposide—uterine cancer	9.18e-05	0.000689	CcSEcCtD
Ketoprofen—Hypertension—Epirubicin—uterine cancer	9.16e-05	0.000688	CcSEcCtD
Ketoprofen—Ill-defined disorder—Doxorubicin—uterine cancer	9.11e-05	0.000684	CcSEcCtD
Ketoprofen—Anaemia—Doxorubicin—uterine cancer	9.08e-05	0.000681	CcSEcCtD
Ketoprofen—Myalgia—Epirubicin—uterine cancer	9.04e-05	0.000678	CcSEcCtD
Ketoprofen—Anxiety—Epirubicin—uterine cancer	9.01e-05	0.000676	CcSEcCtD
Ketoprofen—Discomfort—Epirubicin—uterine cancer	8.93e-05	0.00067	CcSEcCtD
Ketoprofen—Malaise—Doxorubicin—uterine cancer	8.86e-05	0.000665	CcSEcCtD
Ketoprofen—Dry mouth—Epirubicin—uterine cancer	8.84e-05	0.000663	CcSEcCtD
Ketoprofen—Vertigo—Doxorubicin—uterine cancer	8.82e-05	0.000662	CcSEcCtD
Ketoprofen—Confusional state—Epirubicin—uterine cancer	8.73e-05	0.000656	CcSEcCtD
Ketoprofen—Palpitations—Doxorubicin—uterine cancer	8.68e-05	0.000652	CcSEcCtD
Ketoprofen—Oedema—Epirubicin—uterine cancer	8.66e-05	0.00065	CcSEcCtD
Ketoprofen—Anaphylactic shock—Epirubicin—uterine cancer	8.66e-05	0.00065	CcSEcCtD
Ketoprofen—Infection—Epirubicin—uterine cancer	8.61e-05	0.000646	CcSEcCtD
Ketoprofen—Shock—Epirubicin—uterine cancer	8.52e-05	0.00064	CcSEcCtD
Ketoprofen—Convulsion—Doxorubicin—uterine cancer	8.51e-05	0.000639	CcSEcCtD
Ketoprofen—Thrombocytopenia—Epirubicin—uterine cancer	8.48e-05	0.000637	CcSEcCtD
Ketoprofen—Hypertension—Doxorubicin—uterine cancer	8.48e-05	0.000637	CcSEcCtD
Ketoprofen—Tachycardia—Epirubicin—uterine cancer	8.45e-05	0.000635	CcSEcCtD
Ketoprofen—Hyperhidrosis—Epirubicin—uterine cancer	8.37e-05	0.000629	CcSEcCtD
Ketoprofen—Myalgia—Doxorubicin—uterine cancer	8.36e-05	0.000628	CcSEcCtD
Ketoprofen—Anxiety—Doxorubicin—uterine cancer	8.33e-05	0.000626	CcSEcCtD
Ketoprofen—Discomfort—Doxorubicin—uterine cancer	8.26e-05	0.00062	CcSEcCtD
Ketoprofen—Anorexia—Epirubicin—uterine cancer	8.26e-05	0.00062	CcSEcCtD
Ketoprofen—Dry mouth—Doxorubicin—uterine cancer	8.18e-05	0.000614	CcSEcCtD
Ketoprofen—Confusional state—Doxorubicin—uterine cancer	8.08e-05	0.000607	CcSEcCtD
Ketoprofen—Anaphylactic shock—Doxorubicin—uterine cancer	8.02e-05	0.000602	CcSEcCtD
Ketoprofen—Oedema—Doxorubicin—uterine cancer	8.02e-05	0.000602	CcSEcCtD
Ketoprofen—Infection—Doxorubicin—uterine cancer	7.96e-05	0.000598	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Epirubicin—uterine cancer	7.89e-05	0.000592	CcSEcCtD
Ketoprofen—Shock—Doxorubicin—uterine cancer	7.89e-05	0.000592	CcSEcCtD
Ketoprofen—Thrombocytopenia—Doxorubicin—uterine cancer	7.85e-05	0.000589	CcSEcCtD
Ketoprofen—Insomnia—Epirubicin—uterine cancer	7.84e-05	0.000588	CcSEcCtD
Ketoprofen—Tachycardia—Doxorubicin—uterine cancer	7.82e-05	0.000587	CcSEcCtD
Ketoprofen—Paraesthesia—Epirubicin—uterine cancer	7.78e-05	0.000584	CcSEcCtD
Ketoprofen—Hyperhidrosis—Doxorubicin—uterine cancer	7.75e-05	0.000582	CcSEcCtD
Ketoprofen—Dyspnoea—Epirubicin—uterine cancer	7.72e-05	0.00058	CcSEcCtD
Ketoprofen—Somnolence—Epirubicin—uterine cancer	7.7e-05	0.000578	CcSEcCtD
Ketoprofen—Anorexia—Doxorubicin—uterine cancer	7.64e-05	0.000574	CcSEcCtD
Ketoprofen—Dyspepsia—Epirubicin—uterine cancer	7.63e-05	0.000572	CcSEcCtD
Ketoprofen—Decreased appetite—Epirubicin—uterine cancer	7.53e-05	0.000565	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Epirubicin—uterine cancer	7.48e-05	0.000561	CcSEcCtD
Ketoprofen—Fatigue—Epirubicin—uterine cancer	7.47e-05	0.000561	CcSEcCtD
Ketoprofen—Constipation—Epirubicin—uterine cancer	7.41e-05	0.000556	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Doxorubicin—uterine cancer	7.3e-05	0.000548	CcSEcCtD
Ketoprofen—Insomnia—Doxorubicin—uterine cancer	7.25e-05	0.000544	CcSEcCtD
Ketoprofen—Paraesthesia—Doxorubicin—uterine cancer	7.2e-05	0.00054	CcSEcCtD
Ketoprofen—Dyspnoea—Doxorubicin—uterine cancer	7.15e-05	0.000536	CcSEcCtD
Ketoprofen—Feeling abnormal—Epirubicin—uterine cancer	7.14e-05	0.000536	CcSEcCtD
Ketoprofen—Somnolence—Doxorubicin—uterine cancer	7.13e-05	0.000535	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Epirubicin—uterine cancer	7.08e-05	0.000532	CcSEcCtD
Ketoprofen—Dyspepsia—Doxorubicin—uterine cancer	7.06e-05	0.00053	CcSEcCtD
Ketoprofen—Decreased appetite—Doxorubicin—uterine cancer	6.97e-05	0.000523	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Doxorubicin—uterine cancer	6.92e-05	0.000519	CcSEcCtD
Ketoprofen—Fatigue—Doxorubicin—uterine cancer	6.91e-05	0.000519	CcSEcCtD
Ketoprofen—Urticaria—Epirubicin—uterine cancer	6.88e-05	0.000517	CcSEcCtD
Ketoprofen—Constipation—Doxorubicin—uterine cancer	6.85e-05	0.000515	CcSEcCtD
Ketoprofen—Abdominal pain—Epirubicin—uterine cancer	6.85e-05	0.000514	CcSEcCtD
Ketoprofen—Feeling abnormal—Doxorubicin—uterine cancer	6.61e-05	0.000496	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Doxorubicin—uterine cancer	6.55e-05	0.000492	CcSEcCtD
Ketoprofen—Hypersensitivity—Epirubicin—uterine cancer	6.38e-05	0.000479	CcSEcCtD
Ketoprofen—Urticaria—Doxorubicin—uterine cancer	6.37e-05	0.000478	CcSEcCtD
Ketoprofen—Abdominal pain—Doxorubicin—uterine cancer	6.34e-05	0.000476	CcSEcCtD
Ketoprofen—Asthenia—Epirubicin—uterine cancer	6.22e-05	0.000467	CcSEcCtD
Ketoprofen—Pruritus—Epirubicin—uterine cancer	6.13e-05	0.00046	CcSEcCtD
Ketoprofen—Diarrhoea—Epirubicin—uterine cancer	5.93e-05	0.000445	CcSEcCtD
Ketoprofen—Hypersensitivity—Doxorubicin—uterine cancer	5.91e-05	0.000443	CcSEcCtD
Ketoprofen—Asthenia—Doxorubicin—uterine cancer	5.75e-05	0.000432	CcSEcCtD
Ketoprofen—Dizziness—Epirubicin—uterine cancer	5.73e-05	0.00043	CcSEcCtD
Ketoprofen—Pruritus—Doxorubicin—uterine cancer	5.67e-05	0.000426	CcSEcCtD
Ketoprofen—Vomiting—Epirubicin—uterine cancer	5.51e-05	0.000413	CcSEcCtD
Ketoprofen—Diarrhoea—Doxorubicin—uterine cancer	5.48e-05	0.000412	CcSEcCtD
Ketoprofen—Rash—Epirubicin—uterine cancer	5.46e-05	0.00041	CcSEcCtD
Ketoprofen—Dermatitis—Epirubicin—uterine cancer	5.46e-05	0.00041	CcSEcCtD
Ketoprofen—Headache—Epirubicin—uterine cancer	5.43e-05	0.000407	CcSEcCtD
Ketoprofen—Dizziness—Doxorubicin—uterine cancer	5.3e-05	0.000398	CcSEcCtD
Ketoprofen—Nausea—Epirubicin—uterine cancer	5.15e-05	0.000386	CcSEcCtD
Ketoprofen—Vomiting—Doxorubicin—uterine cancer	5.1e-05	0.000383	CcSEcCtD
Ketoprofen—Rash—Doxorubicin—uterine cancer	5.05e-05	0.000379	CcSEcCtD
Ketoprofen—Dermatitis—Doxorubicin—uterine cancer	5.05e-05	0.000379	CcSEcCtD
Ketoprofen—Headache—Doxorubicin—uterine cancer	5.02e-05	0.000377	CcSEcCtD
Ketoprofen—Nausea—Doxorubicin—uterine cancer	4.76e-05	0.000357	CcSEcCtD
Ketoprofen—PTGS2—C-MYB transcription factor network—KRAS—uterine cancer	3.52e-05	0.0008	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—CXCL8—uterine cancer	3.52e-05	0.0008	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—FGFR2—uterine cancer	3.49e-05	0.000794	CbGpPWpGaD
Ketoprofen—ALB—Platelet degranulation—VEGFA—uterine cancer	3.49e-05	0.000792	CbGpPWpGaD
Ketoprofen—ABCC4—Platelet activation, signaling and aggregation—VEGFA—uterine cancer	3.42e-05	0.000776	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—AKR1C1—uterine cancer	3.37e-05	0.000765	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—NDUFB11—uterine cancer	3.32e-05	0.000755	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—SRD5A2—uterine cancer	3.32e-05	0.000755	CbGpPWpGaD
Ketoprofen—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—uterine cancer	3.32e-05	0.000755	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	3.23e-05	0.000734	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	3.22e-05	0.000732	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	3.21e-05	0.000728	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—POLD1—uterine cancer	3.12e-05	0.000709	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—AKR1B10—uterine cancer	3.09e-05	0.000701	CbGpPWpGaD
Ketoprofen—ALB—Folate Metabolism—TP53—uterine cancer	3.07e-05	0.000698	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	3.05e-05	0.000693	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—AKR1B1—uterine cancer	3.03e-05	0.000688	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—STAR—uterine cancer	3.03e-05	0.000688	CbGpPWpGaD
Ketoprofen—PTGS2—C-MYB transcription factor network—HRAS—uterine cancer	3e-05	0.00068	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.99e-05	0.00068	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—ESR1—uterine cancer	2.99e-05	0.000679	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—AKR1C1—uterine cancer	2.92e-05	0.000664	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular responses to stress—TP53—uterine cancer	2.86e-05	0.00065	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—NRAS—uterine cancer	2.83e-05	0.000642	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	2.79e-05	0.000634	CbGpPWpGaD
Ketoprofen—CXCL8—Metabolism of proteins—CCL2—uterine cancer	2.76e-05	0.000626	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—SRD5A2—uterine cancer	2.71e-05	0.000614	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—NDUFB11—uterine cancer	2.71e-05	0.000614	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—IRF1—uterine cancer	2.7e-05	0.000612	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—SRD5A2—uterine cancer	2.69e-05	0.000611	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—NDUFB11—uterine cancer	2.69e-05	0.000611	CbGpPWpGaD
Ketoprofen—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	2.67e-05	0.000606	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—CCL2—uterine cancer	2.63e-05	0.000598	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.63e-05	0.000597	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.62e-05	0.000596	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.61e-05	0.000593	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—RRM2—uterine cancer	2.6e-05	0.000591	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—AKR1C3—uterine cancer	2.59e-05	0.000589	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	2.58e-05	0.000587	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—RNF43—uterine cancer	2.56e-05	0.000581	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—DCN—uterine cancer	2.53e-05	0.000574	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—PGR—uterine cancer	2.53e-05	0.000574	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.48e-05	0.000564	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.47e-05	0.00056	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR downstream signaling—PIK3CA—uterine cancer	2.46e-05	0.000559	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	2.44e-05	0.000554	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—KRAS—uterine cancer	2.43e-05	0.000552	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—YWHAE—uterine cancer	2.41e-05	0.000547	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—AKR1B1—uterine cancer	2.4e-05	0.000546	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—STAR—uterine cancer	2.4e-05	0.000546	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—TP53—uterine cancer	2.39e-05	0.000542	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—CYP11A1—uterine cancer	2.38e-05	0.000541	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	2.38e-05	0.00054	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—POLD1—uterine cancer	2.38e-05	0.00054	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.38e-05	0.00054	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—FBXW7—uterine cancer	2.31e-05	0.000525	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	2.27e-05	0.000515	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—AKR1C3—uterine cancer	2.25e-05	0.000511	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—PIK3CA—uterine cancer	2.23e-05	0.000507	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—AKR1C1—uterine cancer	2.22e-05	0.000505	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—SRD5A2—uterine cancer	2.2e-05	0.0005	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—NDUFB11—uterine cancer	2.2e-05	0.0005	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—ERBB2—uterine cancer	2.19e-05	0.000498	CbGpPWpGaD
Ketoprofen—ABCC4—Platelet activation, signaling and aggregation—AKT1—uterine cancer	2.18e-05	0.000495	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	2.15e-05	0.000488	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.14e-05	0.000486	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—AKR1C1—uterine cancer	2.11e-05	0.000478	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—CXCL8—uterine cancer	2.08e-05	0.000473	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—HRAS—uterine cancer	2.07e-05	0.00047	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—CDKN1B—uterine cancer	2.03e-05	0.000461	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—STK11—uterine cancer	2.02e-05	0.000459	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.02e-05	0.000459	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—CCL2—uterine cancer	2.01e-05	0.000457	CbGpPWpGaD
Ketoprofen—CXCL8—Metabolism of proteins—CTNNB1—uterine cancer	2.01e-05	0.000457	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR downstream signaling—AKT1—uterine cancer	2.01e-05	0.000457	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—RRM2—uterine cancer	1.98e-05	0.00045	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—AKR1B1—uterine cancer	1.96e-05	0.000444	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—STAR—uterine cancer	1.96e-05	0.000444	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—STAR—uterine cancer	1.94e-05	0.000442	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—AKR1B1—uterine cancer	1.94e-05	0.000442	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.93e-05	0.000439	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—DCN—uterine cancer	1.92e-05	0.000437	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.92e-05	0.000437	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—CTNNB1—uterine cancer	1.92e-05	0.000436	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—SOCS3—uterine cancer	1.89e-05	0.00043	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—POLD1—uterine cancer	1.89e-05	0.000428	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—PTEN—uterine cancer	1.87e-05	0.000425	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—EP300—uterine cancer	1.86e-05	0.000423	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	1.83e-05	0.000415	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—AKT1—uterine cancer	1.83e-05	0.000415	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—DCN—uterine cancer	1.82e-05	0.000414	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—CYP11A1—uterine cancer	1.81e-05	0.000411	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CDKN2B—uterine cancer	1.81e-05	0.000411	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—EP300—uterine cancer	1.78e-05	0.000405	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—AKR1C1—uterine cancer	1.76e-05	0.000401	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—VEGFA—uterine cancer	1.76e-05	0.0004	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—IGF1R—uterine cancer	1.76e-05	0.000399	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—STK11—uterine cancer	1.75e-05	0.000398	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—CYP19A1—uterine cancer	1.75e-05	0.000398	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—NRAS—uterine cancer	1.74e-05	0.000395	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—AKR1C3—uterine cancer	1.71e-05	0.000389	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—VEGFA—uterine cancer	1.69e-05	0.000384	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	1.68e-05	0.000381	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—NRAS—uterine cancer	1.67e-05	0.000379	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—SMAD3—uterine cancer	1.65e-05	0.000375	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.64e-05	0.000374	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	1.62e-05	0.000369	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—AKR1C3—uterine cancer	1.62e-05	0.000368	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—STAR—uterine cancer	1.59e-05	0.000362	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—AKR1B1—uterine cancer	1.59e-05	0.000362	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—HMGA1—uterine cancer	1.58e-05	0.000359	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—FGFR2—uterine cancer	1.58e-05	0.000358	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.57e-05	0.000357	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—RRM2—uterine cancer	1.57e-05	0.000357	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.57e-05	0.000356	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—VEGFA—uterine cancer	1.55e-05	0.000351	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—POLD1—uterine cancer	1.53e-05	0.000349	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—DCN—uterine cancer	1.53e-05	0.000347	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—POLD1—uterine cancer	1.53e-05	0.000347	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—KRAS—uterine cancer	1.5e-05	0.00034	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—FBXW7—uterine cancer	1.45e-05	0.000328	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—CYP11A1—uterine cancer	1.44e-05	0.000327	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—KRAS—uterine cancer	1.44e-05	0.000326	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—AKR1C1—uterine cancer	1.44e-05	0.000326	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—AKR1C1—uterine cancer	1.43e-05	0.000324	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—PIK3CA—uterine cancer	1.38e-05	0.000313	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	1.37e-05	0.000311	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—AKR1C3—uterine cancer	1.36e-05	0.000308	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—ESR1—uterine cancer	1.35e-05	0.000306	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—STK11—uterine cancer	1.33e-05	0.000303	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—CYP19A1—uterine cancer	1.33e-05	0.000303	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—TP53—uterine cancer	1.33e-05	0.000302	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—PIK3CA—uterine cancer	1.32e-05	0.0003	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—MTHFR—uterine cancer	1.32e-05	0.000299	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—RRM2—uterine cancer	1.28e-05	0.000291	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—TP53—uterine cancer	1.28e-05	0.00029	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—NRAS—uterine cancer	1.28e-05	0.00029	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—HRAS—uterine cancer	1.27e-05	0.000289	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—RRM2—uterine cancer	1.27e-05	0.000289	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.25e-05	0.000284	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—POLD1—uterine cancer	1.25e-05	0.000284	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—DCN—uterine cancer	1.24e-05	0.000282	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—DCN—uterine cancer	1.24e-05	0.000281	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—HRAS—uterine cancer	1.22e-05	0.000277	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	1.21e-05	0.000274	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.19e-05	0.000271	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CCL2—uterine cancer	1.19e-05	0.00027	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—CYP11A1—uterine cancer	1.17e-05	0.000266	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—AKR1C1—uterine cancer	1.17e-05	0.000265	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—CYP11A1—uterine cancer	1.16e-05	0.000264	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.16e-05	0.000264	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—CDKN2B—uterine cancer	1.13e-05	0.000257	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—AKT1—uterine cancer	1.12e-05	0.000255	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—PIK3CA—uterine cancer	1.11e-05	0.000252	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—AKR1C3—uterine cancer	1.11e-05	0.000251	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—AKR1C3—uterine cancer	1.1e-05	0.00025	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—KRAS—uterine cancer	1.1e-05	0.000249	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—AKT1—uterine cancer	1.08e-05	0.000245	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—STK11—uterine cancer	1.06e-05	0.00024	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—CYP19A1—uterine cancer	1.06e-05	0.00024	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—RRM2—uterine cancer	1.04e-05	0.000237	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—SMAD3—uterine cancer	1.03e-05	0.000235	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—DCN—uterine cancer	1.01e-05	0.00023	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—PIK3CA—uterine cancer	1.01e-05	0.000229	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—MTHFR—uterine cancer	1e-05	0.000228	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	9.93e-06	0.000226	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—ERBB2—uterine cancer	9.9e-06	0.000225	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—AKT1—uterine cancer	9.87e-06	0.000224	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—FGFR2—uterine cancer	9.86e-06	0.000224	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—CYP11A1—uterine cancer	9.52e-06	0.000216	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—MTHFR—uterine cancer	9.5e-06	0.000216	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	9.47e-06	0.000215	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—HRAS—uterine cancer	9.33e-06	0.000212	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CDKN1B—uterine cancer	9.17e-06	0.000208	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—AKT1—uterine cancer	9.07e-06	0.000206	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—AKR1C3—uterine cancer	8.99e-06	0.000204	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	8.83e-06	0.0002	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CTNNB1—uterine cancer	8.66e-06	0.000197	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—STK11—uterine cancer	8.61e-06	0.000196	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—CYP19A1—uterine cancer	8.61e-06	0.000196	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—STK11—uterine cancer	8.56e-06	0.000194	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—CYP19A1—uterine cancer	8.56e-06	0.000194	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—PTEN—uterine cancer	8.44e-06	0.000192	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—EP300—uterine cancer	8.42e-06	0.000191	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—AKT1—uterine cancer	8.24e-06	0.000187	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	8.08e-06	0.000184	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—EP300—uterine cancer	8.05e-06	0.000183	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	8.04e-06	0.000183	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—VEGFA—uterine cancer	7.97e-06	0.000181	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—MTHFR—uterine cancer	7.95e-06	0.000181	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—NRAS—uterine cancer	7.88e-06	0.000179	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	7.71e-06	0.000175	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—EP300—uterine cancer	7.66e-06	0.000174	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—VEGFA—uterine cancer	7.63e-06	0.000173	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—NRAS—uterine cancer	7.53e-06	0.000171	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PTEN—uterine cancer	7.33e-06	0.000166	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—STK11—uterine cancer	7.01e-06	0.000159	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—CYP19A1—uterine cancer	7.01e-06	0.000159	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	7.01e-06	0.000159	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—EP300—uterine cancer	6.99e-06	0.000159	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—KRAS—uterine cancer	6.78e-06	0.000154	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	6.58e-06	0.000149	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—KRAS—uterine cancer	6.48e-06	0.000147	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—MTHFR—uterine cancer	6.47e-06	0.000147	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—MTHFR—uterine cancer	6.43e-06	0.000146	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	6.27e-06	0.000142	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—PIK3CA—uterine cancer	6.23e-06	0.000141	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—ERBB2—uterine cancer	6.19e-06	0.000141	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—TP53—uterine cancer	6.02e-06	0.000137	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—PIK3CA—uterine cancer	5.96e-06	0.000135	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—TP53—uterine cancer	5.76e-06	0.000131	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—HRAS—uterine cancer	5.76e-06	0.000131	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—CDKN1B—uterine cancer	5.74e-06	0.00013	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.7e-06	0.00013	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.67e-06	0.000129	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PTEN—uterine cancer	5.57e-06	0.000127	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—HRAS—uterine cancer	5.51e-06	0.000125	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—CTNNB1—uterine cancer	5.42e-06	0.000123	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—EP300—uterine cancer	5.31e-06	0.000121	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—PTEN—uterine cancer	5.28e-06	0.00012	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—MTHFR—uterine cancer	5.27e-06	0.00012	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PIK3CA—uterine cancer	5.17e-06	0.000117	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—AKT1—uterine cancer	5.09e-06	0.000116	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—EP300—uterine cancer	5.04e-06	0.000114	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—AKT1—uterine cancer	4.87e-06	0.000111	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—NRAS—uterine cancer	4.71e-06	0.000107	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.64e-06	0.000105	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—PTEN—uterine cancer	4.42e-06	0.0001	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—AKT1—uterine cancer	4.22e-06	9.59e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—EP300—uterine cancer	4.22e-06	9.58e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—KRAS—uterine cancer	4.06e-06	9.21e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PIK3CA—uterine cancer	3.93e-06	8.93e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—PIK3CA—uterine cancer	3.73e-06	8.46e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PTEN—uterine cancer	3.6e-06	8.18e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PTEN—uterine cancer	3.58e-06	8.13e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—HRAS—uterine cancer	3.45e-06	7.83e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—EP300—uterine cancer	3.43e-06	7.8e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—EP300—uterine cancer	3.41e-06	7.75e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—AKT1—uterine cancer	3.21e-06	7.29e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—PIK3CA—uterine cancer	3.12e-06	7.09e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—AKT1—uterine cancer	3.04e-06	6.91e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PTEN—uterine cancer	2.93e-06	6.65e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—EP300—uterine cancer	2.79e-06	6.35e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—AKT1—uterine cancer	2.55e-06	5.79e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PIK3CA—uterine cancer	2.54e-06	5.77e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PIK3CA—uterine cancer	2.52e-06	5.73e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—AKT1—uterine cancer	2.07e-06	4.71e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PIK3CA—uterine cancer	2.07e-06	4.69e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—AKT1—uterine cancer	2.06e-06	4.68e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—AKT1—uterine cancer	1.69e-06	3.83e-05	CbGpPWpGaD
